Target intelligence / Profile preview

Transmembrane protease, serine 3 (TMPRSS3)

Target
TMPRSS3
Molecular classification
Enzyme, Serine protease, Transmembrane protein, Type II transmembrane serine protease
01

Overview

Transmembrane protease, serine 3 (TMPRSS3) is a type II transmembrane serine protease containing a serine protease domain, a transmembrane domain, a low-density lipoprotein receptor class A (LDLRA) domain, and a scavenger receptor cysteine-rich domain. It is essential for the survival and activation of cochlear hair cells and is required for proper hearing. TMPRSS3 mutations cause autosomal recessive nonsyndromic hearing loss (DFNB8/10). It is also expressed in various tissues and is overexpressed in some tumors, including ovarian cancer. TMPRSS3 is involved in proteolytic regulation of ion channels, particularly those important for auditory transduction and cochlear cell maintenance. No drugs specifically target TMPRSS3 clinically, but its genetic variants are used as diagnostic biomarkers for hereditary deafness syndromes.

Other names
ECHOS1TADG12UNQ323/PRO382Serine protease TADG-12Tumor-associated differentially-expressed gene 12 proteinDFNB10DFNB8transmembrane protease serine 3
02

Mechanism of action

Not directly drug-targeted; general mechanism is proteolysis of target proteins in cellular and extracellular contexts, impacting ion channel regulation and hair cell survival

03

Biological functions

Proteolysis (serine-type endopeptidase activity)Regulation of hearing (cochlear hair cell survival and activation)Sodium channel regulator activityPossibly signal transduction in supporting cellsDevelopment and maintenance of inner ear structures
04

Disease associations

Deafness (autosomal recessive nonsyndromic deafness DFNB8/DFNB10)Cancer (tumor-associated gene, notably ovarian cancer overexpression)Hearing loss (congenital and childhood-onset)
05

Safety considerations

Potential for off-target effects on hair cell viability and development if therapeutically targetedRisk of interfering with auditory or vestibular functions due to essential roles in cochlear hair cell maintenance
06

Biomarkers

Pathogenic/likely pathogenic TMPRSS3 variants serve as biomarkers for genetic diagnostic testing of hereditary deafness (DFNB8/DFNB10)

Beyond the preview

Go deeper on Transmembrane protease, serine 3 (TMPRSS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protease, serine 3 (TMPRSS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call